5 Reasons to Buy Regeneron Stock and Never Sell
Regeneron Pharmaceuticals (NASDAQ: REGN) is arguably one of the best-performing biotech stocks of the past decade, with its shares up more than 2,050% since 2010, beating the S&P 500's 192% return in the same period hands down. While many biotech stocks quickly lose their revenue momentum after patents on their biologics expire, Regeneron is constantly reinvesting a significant portion of its cash flows back into its business for the sake of innovation. Today, let us look at why Regeneron is a glimpse of what the high-flying biotech sector has to offer, and why you should buy and hold its shares forever.
